PD-1 immunotherapy in pancreatic cancer: current status
Chap 1,growth of imc
GM and PM values with IMC-1
HIV-1 fitness cost associated with escape from the VRC01 class of CD4
Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen
Phase Margin - an overview
PDF] Probably the best simple PID tuning rules in the world
GM and PM values with IMC-1
Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen - ScienceDirect